Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.83B |
| 2 |
Wells Fargo
WFC
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Home Depot
HD
|
+$247M |
| 5 |
Alibaba
BABA
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$414M |
| 2 |
Lowe's Companies
LOW
|
+$326M |
| 3 |
Las Vegas Sands
LVS
|
+$265M |
| 4 |
AABA
Altaba Inc
AABA
|
+$249M |
| 5 |
NBL
Noble Energy, Inc.
NBL
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.65% |
| 2 | Technology | 8.5% |
| 3 | Financials | 8.48% |
| 4 | Consumer Discretionary | 7.65% |
| 5 | Industrials | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Vail Resorts
MTN
$5.7B
| $764K | ﹤0.01% |
3,184
-124,366
| -98% | -$29.4M |
|
|
TRCB
3102
DELISTED
Two River Bancorp
TRCB
| $762K | ﹤0.01% |
33,998
+19,476
| +134% | +$413K |
|
|
AZUL
3103
DELISTED
Azul
AZUL
| $759K | ﹤0.01% |
17,742
-69,514
| -80% | -$2.68M |
|
3104
NVE Corp
NVEC
$543M
| $759K | ﹤0.01% |
10,631
-36,274
| -77% | -$2.36M |
|
3105
Toll Brothers
TOL
$14B
| $759K | ﹤0.01% |
19,211
-79,403
| -81% | -$3.17M |
|
3106
Universal Technical Institute
UTI
$2.26B
| $758K | ﹤0.01% |
+98,261
| New | +$592K |
|
|
VRTU
3107
DELISTED
Virtusa Corporation
VRTU
| $758K | ﹤0.01% |
16,713
-30,320
| -64% | -$1.24M |
|
|
NYMX
3108
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $757K | ﹤0.01% |
344,057
-111,037
| -24% | -$219K |
|
3109
Kimbell Royalty Partners
KRP
$1.46B
| $754K | ﹤0.01% |
44,376
-10,695
| -19% | -$159K |
|
|
KRA
3110
DELISTED
Kraton Corporation
KRA
| $751K | ﹤0.01% |
29,648
+13,213
| +80% | +$320K |
|
|
SWI
3111
DELISTED
SolarWinds Corporation Common Stock
SWI
| $751K | ﹤0.01% |
38,377
-44,575
| -54% | -$884K |
|
3112
American Coastal Insurance
ACIC
$536M
| $750K | ﹤0.01% |
59,511
-307,522
| -84% | -$3.91M |
|
3113
CoStar Group
CSGP
$12.2B
| $750K | ﹤0.01% |
12,540
-1,368,120
| -99% | -$79.9M |
|
3114
Adeia
ADEA
$2.55B
| $748K | ﹤0.01% |
+152,841
| New | +$812K |
|
3115
CALL
Jazz Pharmaceuticals
JAZZ
$16.1B
| $746K | ﹤0.01% |
+5,000
| New | +$680K |
|
3116
CALL
HealthEquity
HQY
$8.71B
| $741K | ﹤0.01% |
+10,000
| New | +$624K |
|
3117
PUT
Bio-Rad Laboratories Class A
BIO
$8.76B
| $740K | ﹤0.01% |
2,000
| – | – |
|
3118
Columbia Banking Systems
COLB
$8.71B
| $739K | ﹤0.01% |
18,175
-33,201
| -65% | -$1.29M |
|
3119
Sonic Automotive
SAH
$3.56B
| $739K | ﹤0.01% |
23,854
-287,362
| -92% | -$9.09M |
|
3120
Cencora
COR
$62B
| $735K | ﹤0.01% |
+8,647
| New | +$741K |
|
3121
Veeco
VECO
$2.62B
| $734K | ﹤0.01% |
+49,963
| New | +$680K |
|
3122
First Business Financial Services
FBIZ
$565M
| $733K | ﹤0.01% |
27,831
+12,689
| +84% | +$315K |
|
|
CLSD
3123
DELISTED
Clearside Biomedical
CLSD
| $728K | ﹤0.01% |
16,737
-1,965
| -11% | -$41.3K |
|
3124
CNX Resources
CNX
$4.91B
| $726K | ﹤0.01% |
82,062
-2,278,510
| -97% | -$17.8M |
|
3125
Costamare
CMRE
$1.85B
| $725K | ﹤0.01% |
76,036
-752,240
| -91% | -$6.01M |
|
Similar funds
Millennium Management's Q4 2019 Portfolio in Review
As of Q4 2019, Millennium Management held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Millennium Management deployed $9.74B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.
By sector, the portfolio is most concentrated in Healthcare at 9.7% of assets, down from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.
- Millennium Management's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
- Millennium Management's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
- Millennium Management fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
- Millennium Management's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
- Millennium Management opened 829 new positions and closed 796 in Q4 2019.
- Millennium Management's portfolio value rose 26% quarter-over-quarter to $79.9B.
Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.